logo

CLOV

Clover Health·NASDAQ
--
--(--)
--
--(--)
4.54 / 10
Netural

Clover Health's fundamentals are mixed: factors like Profit-MV and Cash-UP score well, but YoY declines in ROE and operating cash flow temper the outlook. The company is targeting its first GAAP profitability through cost control, which could improve the fundamental picture over time.

Fundamental(4.54)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value0.88
Score1/3
Weight2.45%
1M Return0.69%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight11.55%
1M Return2.83%
ROE (diluted) (YoY growth rate %)
Value-9.75
Score1/3
Weight9.90%
1M Return2.38%
Profit-MV
Value0.46
Score2/3
Weight13.88%
1M Return3.60%
Basic earnings per share (YoY growth rate %)
Value-75.00
Score3/3
Weight24.14%
1M Return5.12%
Total profit (YoY growth rate %)
Value-46.17
Score3/3
Weight24.87%
1M Return5.23%
Net cash flow from operating activities (YoY growth rate %)
Value-98.99
Score0/3
Weight-1.61%
1M Return-0.49%
Current assets turnover ratio
Value4.26
Score1/3
Weight5.34%
1M Return1.68%
Cash-UP
Value0.31
Score2/3
Weight6.14%
1M Return1.88%
Asset-MV
Value-0.50
Score0/3
Weight3.34%
1M Return0.91%
Is CLOV fundamentally strong?
  • CLOV scores 4.54/10 on fundamentals and holds a Fair valuation at present. Backed by its -10.62% ROE, -3.29% net margin, -18.87 P/E ratio, 3.23 P/B ratio, and 42.11% earnings growth, these metrics solidify its Netural investment rating.